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ABSTRACT
Objective: To verify the prevalence of metabolic syn-
drome and insulin resistance in obese adolescents and its 
relationship with different body composition indicators. 
Methods: A cross-sectional study comprising 79 ado-
lescents aged ten to 18 years old. The assessed body com-
position indicators were: body mass index (BMI), body fat 
percentage, abdominal circumference, and subcutaneous 
fat. The metabolic syndrome was diagnosed according to 
the criteria proposed by Cook et al. The insulin resistance 
was determined by the Homeostasis Model Assessment for In-
sulin Resistance (HOMA-IR) index for values above 3.16. 
The analysis of ROC curves was used to assess the BMI and 
the abdominal circumference, aiming to identify the subjects 
with metabolic syndrome and insulin resistance. The cutoff 
point corresponded to the percentage above the reference 
value used to diagnose obesity.
Results: The metabolic syndrome was diagnosed in 
45.5% of the patients and insulin resistance, in 29.1%. 
Insulin resistance showed association with HDL-cholesterol 
(p=0.032) and with metabolic syndrome (p=0.006). All 
body composition indicators were correlated with insulin 
resistance (p<0.01). In relation to the cutoff point evaluation, 
the values of 23.5 and 36.3% above the BMI reference point 
allowed the identification of insulin resistance and metabolic 
syndrome. The best cutoff point for abdominal circumference 
to identify insulin resistance was 40%. 
Conclusions: All body composition indicators, 
HDL-cholesterol and metabolic syndrome showed correla-
tion with insulin resistance. The BMI was the most effective 
anthropometric indicator to identify insulin resistance.
Keywords: metabolic syndrome x; insulin resistance; 
obesity; adolescent; body composition; anthropometry.
RESUMO
Objetivo: Verificar a prevalência da síndrome metabólica 
e da resistência à insulina em adolescentes obesos e sua relação 
com diferentes indicadores de composição corporal. 
Métodos: Estudo transversal com 79 adolescentes de dez a 
18 anos. Os indicadores de composição corporal foram: índice 
de massa corpórea (IMC), porcentagem de gordura corporal, 
circunferência abdominal e gordura subcutânea. A síndrome 
metabólica foi diagnosticada segundo os critérios de Cook et al. 
A resistência à insulina foi determinada pelo índice de Homeos-
tasis Model Assessment for Insulin Resistance (HOMA-IR) para 
valores acima de 3,16. Utilizou-se a análise de curvas ROC para 
avaliar o IMC e a circunferência abdominal, identificando-se os 
indivíduos com resistência à insulina e síndrome metabólica. 
O ponto de corte correspondeu ao percentual acima do valor 
de referência para o diagnóstico de obesidade. 
Resultados: A síndrome metabólica foi diagnostica-
da em 45,5% dos pacientes e a resistência à insulina, em 
29,1%. A resistência à insulina apresentou associação com 
o HDL-colesterol (p=0,032) e com a síndrome metabólica 
(p=0,006). Todos os indicadores de composição corporal 
avaliados apresentaram correlação com a resistência à insulina 
(p<0,01). Na avaliação dos pontos de corte, os valores de 23,5 
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e 36,3% acima do valor de referência do IMC permitiram 
identificar a resistência à insulina e a síndrome metabólica. 
O melhor ponto de corte da circunferência abdominal para 
identificar a resistência à insulina foi de 40%. 
Conclusões: Todos os indicadores de composição corporal, 
o HDL-colesterol e a síndrome metabólica apresentaram 
correlação com a resistência à insulina. O IMC mostrou-se 
o indicador antropométrico mais eficaz para identificar a 
resistência à insulina.
Palavras-chave: síndrome x metabólica; resistência 
à insulina; obesidade; adolescente; composição corporal; 
antropometria.
RESUMEN
Objetivo: Verificar la prevalencia del síndrome metabóli-
co y de la resistencia a la insulina en adolescentes obesos y su 
relación con distintos indicadores de composición corporal. 
Métodos: Estudio transversal con 79 adolescentes de 10 
a 18 años. Los indicadores de composición corporal fueron: 
índice de masa corporal (IMC), porcentaje de grasa corporal, 
circunferencia abdominal y grasa subcutánea. El síndrome 
metabólico fue diagnosticado conforme a los criterios de 
Cook et al. La resistencia a la insulina fue determinada por 
el índice de Homeostasis Model Assessment for Insulin Resistence 
(HOMA-IR) para valores superiores a 3,16. Se utilizó el aná-
lisis de curvas ROC para evaluar el IMC y la circunferencia 
abdominal, identificándose los individuos con resistencia a 
la insulina y síndrome metabólico. El punto de corte corres-
pondió al porcentaje superior al valor de referencia para el 
diagnóstico de obesidad.
Resultados: El síndrome metabólico fue diagnosticado 
en 45,5% de los pacientes y la resistencia a la insulina, en 
29,1%. La resistencia a la insulina presentó asociación con 
el HDL-colesterol (p=0,032) y con el síndrome metabólico 
(p=0,006). Todos los indicadores de composición corporal 
evaluados presentaron correlación con la resistencia a la in-
sulina (p<0,01). En la evaluación de los puntos de corte, los 
valores de 23,5 y 36,3% por encima del valor de referencia 
del IMC permitieron identificar la resistencia a la insulina 
y el síndrome metabólico. El mejor punto de corte de la 
circunferencia abdominal para identificar la resistencia a 
la insulina fue de 40%.
Conclusiones: Todos los indicadores de composición 
corporal, el HDL-colesterol y el síndrome metabólico 
presentaron correlación con la resistencia a la insulina. 
El IMC se mostró el indicador antropométrico más eficaz 
para identificar la resistencia a la insulina.
Palabras clave: síndrome x metabólico; resistencia a 
la insulina; obesidad; adolescente; composición corporal; 
antropometría.
Introduction
Recent data obtained from the Household Budget Survey 
(HBS) from 2008 to 2009, confirmed the sharp increase 
in obesity in adolescents over the last 34 years in Brazil. 
The prevalence increased from 0.4% (1974–1975) to 5.9% 
(2008–2009) in boys and from 0.7 to 4.0% in girls(1). 
The concern with the occurrence of obesity is related to 
the development of comorbidities and complications caused 
by excess weight. The fat accumulation is associated with 
the presence of hypertension and metabolic changes, such 
as increased triglyceride and blood glucose levels and low 
HDL-cholesterol(2). Metabolic syndrome (MS) is a disorder 
represented by a set of risk factors for cardiovascular disease 
and, in children and adolescents, the initial changes of each 
of the factors of MS may occur in varied associations, which, 
even with little expression, determine an unfavorable car-
diovascular profile for these young people(3).
The level of risk for cardiovascular disease in children rises 
with increasing obesity(2). The result is early deposition of 
fatty plaques in the coronary arteries of adolescents(4); and 
the outcome in adulthood is the high incidence of premature 
mortality from cardiovascular disease in individuals who 
were obese adolescents(5). 
Insulin resistance means a reduced ability of insulin to 
stimulate glucose utilization. Pancreatic β-cells increase 
the production and secretion of insulin as a compensatory 
mechanism (hyperinsulinemia), while glucose tolerance 
remains normal(6). Insulin resistance has been identified as 
a problem of collective health and affects even children and 
adolescents.
Indicators of body composition are strongly associated 
with metabolic changes, and it is important to verify their 
relationship with components of metabolic syndrome(7,8) and 
with insulin resistance(2,9,10).
The assessment of cardiovascular risk by different body 
composition indexes in adolescents is poorly studied, and the 
definition of which anthropometric measure correlates better 
with the components of MS and insulin resistance remains 
controversial. The identification of anthropometric measures 
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that are associated to cardiovascular risk factors in adolescents 
may be useful for preventing cardiovascular diseases in the 
future. Thus, this study examined the prevalence of meta-
bolic syndrome and insulin resistance in obese adolescents, 
correlating them to different indicators of body composition.
Method
Cross-sectional study with adolescents in the Child and 
Adolescent Obesity Outpatient Clinic at Hospital de Clínicas 
da Faculdade de Ciências Médicas (School of Medical Sciences), 
Universidade Estadual de Campinas (Unicamp). All adoles-
cents treated from April 2011 to May 2012 who presented 
body mass index (BMI) ≥P
97
 for age and sex, according to 
the charts of the World Health Organization(11) were invited 
to participate. We analyzed the clinical, laboratory, and ul-
trasonographic characteristics of 79 patients of both sexes, 
aged from 10 to 18 years, diagnosed with obesity and whose 
parents/guardians signed an informed consent form. 
The anthropometric techniques used to measure weight 
and height were recommended by Lohman et al(12). BMI was 
calculated by the Quetelet index (BMI=weight/height2). 
Waist circumference was measured with tape measure 
(Sanny®), at the midpoint between the last rib and the upper 
border of the iliac crest. The values obtained were evaluated 
using the data proposed by Fernández et al(13), which con-
sider risk measures of waist circumference ≥P
75
, according 
to gender and age. 
The percentage of body fat was measured by dual energy 
X-ray absorptiometry (DXA), with Hologic® appliance, 
model Discovery QDR series n. 1005-75. The reference 
criterion for increased fat percentage suggested by Williams 
et al(14) is >25% for boys and >30% for girls, being used as 
a cutoff point for classification.
Subcutaneous fat was measured by abdominal ultrasound, 
with a Toshiba® appliance, Model Power Vision 6000 and 
7.5MHz linear transducer. All examinations were performed 
by the same examiner, with the patient in supine position 
after fasting for 12 hours. The transducer was positioned on 
the midline 1cm above the umbilicus, without exerting any 
pressure on the abdomen, in order not to underestimate the 
measurement. Subcutaneous fat was measured as the distance 
(cm) between the skin and the outer face of the fascia of the 
rectus abdominis muscle.
Blood pressure was evaluated with mercury sphygmo-
manometer (Unitec®), using cuff sizes appropriate to the 
patient’s arm circumference, according to the procedures 
recommended by The Brazilian Society of Hypertension. 
Hypertension was defined from blood pressure values ≥P
95
 
for age, sex, and height percentile.
For laboratory analysis of biochemical tests, blood samples 
were collected by venipuncture in the morning after fasting for 
12 hours. Analysis of fasting blood glucose and lipid profile 
was performed by enzymatic colorimetric with reagent kit 
from Roche Diagnostics Lab®. To quantitate basal insulin, we 
used reagent kit by Lab Siemens Healthcare Diagnostics® and 
chemiluminescence method. Diagnosis of diabetes mellitus 
was established in patients with fasting glucose ≥126mg/dL. 
We considered an abnormal lipid profile when the follow-
ing values  were obtained: total cholesterol ≥150mg/dL, 
LDL-cholesterol ≥100mg/dL, HDL-cholesterol <45mg/dL, and 
triglycerides ≥100mg/dL. The diagnosis of insulin resistance 
was determined by Homeostasis Model Assessment index 
for Insulin Resistance (HOMA-IR), which is the product 
of fasting insulin (mIU/mL) and fasting glucose (mmol/L) 
divided by 22.5. Insulin resistance was defined when values 
were above 3.16(15).
MS was diagnosed according to data from Cook et al(3), 
considering the presence of three or more of the following cri-
teria: triglycerides ≥100mg/dL, fasting glucose ≥110mg/dL, 
HDL-cholesterol ≤40mg/dL, systolic or diastolic blood 
pressure ≥P
90
 for age, sex, and height percentile, and waist 
circumference ≥P
90
 for age and sex.
Data were analyzed in the IBM Statistical Package for 
the Social Sciences (SPSS), version 20.0. A descriptive 
analysis of continuous variables included the calculation 
of means and their respective standard deviations, whereas 
categorical variables had their percentages calculated. The 
Kolmogorov-Smirnov test was used to assess normality of 
distribution of variables. For variables with normal distribu-
tion, Pearson’s correlation test was used and, for those who 
did not present normal distribution, Spearman’s correlation 
test was used. The comparison between two independent 
groups was performed by Student’s t test for variables that 
passed the normality test; for variables with n<30 or with-
out normal distribution, we used the Mann-Whitney’s test. 
The Kruskall-Wallis test was used to compare the distribu-
tion of variables by tertiles of the HOMA-IR. We used the 
Bonferroni’s post-hoc test for comparison between groups.
The hypothesis of dependence between categorical vari-
ables was analyzed by chi-square or Fisher’s exact test, when 
appropriate. Values for Odds Ratio (OR) and their respective 
confidence intervals of 95% (95%CI) were calculated to assess 
the strength of dependence between the categorical variables.
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The analysis of the ROC (receiver operating characteristic 
curve) curves, performed with MedCalc 9.3., was used to evalu-
ate the performance of BMI and waist circumference, identify-
ing, among obese individuals, those with insulin resistance and 
metabolic syndrome. As this is a population of adolescents with 
cutoffs for classification of BMI and waist circumference that 
vary according to sex and age, we used the increased percentage 
of BMI and waist circumference regarding the reference value 
for the diagnosis of obesity (P
75
 for waist circumference and P
97
 
for BMI) in determined age and sex. The areas under the ROC 
curves were calculated to evaluate the discriminating power of 
the variables (BMI to identify MS and insulin resistance, and 
waist circumference to identify insulin resistance). We used 
95%CI. We calculated the sensitivity and specificity values 
for all percentages of increased BMI and waist circumference 
in the sample. The cutoff point with the highest sum of sensi-
tivity and specificity was chosen to optimize the relationship 
between these two parameters, reflecting greater accuracy in 
the diagnosis. The level of significance established was less than 
5% (p<0.05) for all tests.
This study was approved by the Research Ethics 
Committee of the School of Medical Sciences at Unicamp, 
in December 2010, under number 872/2010. 
Results
In the present study 79 patients were evaluated, among 
which 39 (49.3%) were female, aged from 10 to 18 years 
(mean 12.8 years), treated at the Child and Adolescent 
Obesity Outpatient Clinic at Hospital de Clínicas da 
Faculdade de Ciências Médicas, Unicamp.
The percentage of body fat differed significantly between 
males and females being higher in girls. Insulin resistance 
measured by HOMA-IR, as well as serum insulin, also 
differed significantly; likewise, the values were higher in 
girls (Table 1).
MS was diagnosed in 36 patients (45.5%), 19 (52.8%) 
females and 17 (47.2%) females. The mean HOMA-IR was 
significantly higher in patients with SM, as well as BMI and 
LDL-cholesterol. 
Among the analyzed patients, 23 (29.1%) presented in-
sulin resistance, with 13 (56.5%) females and 10 (43.5%) 
males. The means for waist circumference, BMI, subcutane-
ous fat, and percentage of body fat were greater for patients 
with insulin resistance. Mean HDL-cholesterol was signifi-
cantly lower in the patients with insulin resistance(Table 2).
When the association test was applied, insulin resistance 
was significantly associated with HDL-cholesterol — 
that was below the amount considered appropriate by the 
Brazilian Society of Cardiology in 19 (82.6%) patients 
(p=0.032; OR=3.56; 95%CI 1.07–11.84) — and with MS 
(p=0.006; OR=4.11; 95%CI 1.45–11.67).
All indicators of body composition were positively cor-
related with insulin resistance. Regarding the components 
of MS, only the systolic and diastolic pressures were sig-
nificantly correlated with BMI, waist circumference, and 
*Mann-Whitney’s test for all variables; HOMA-IR: Homeostasis Model Assessment for Insulin Resistance 
Table 1 - Clinical and biochemical characteristics of the analyzed adolescents, according to sex
Sex Total
(n=79)
p-value*Female
(n=39)
Male
(n=40)
Age (years) 12.9±2.7 12.7±1.9 12.8 ±2.3 0.750
Systolic blood pressure (mmHg) 111.0±12.0 116.0±17.0 114.0±15.0 0.194
Diastolic blood pressure (mmHg) 73.0±10.0 75.0±11.0 74.0±11.0 0.393
Waist circumference (cm) 100.6±10.7 102.8±14.3 101.7±12.6 0.372
Body mass index (kg/m2) 32.2±4.9 31.8±5.6 32.0±5.2 0.610
Body fat (%) 43.3±3.8 39.9±5.7 41.6±5.1 0.003
Subcutaneous fat (cm) 4.2±0.8 4.2±1.2 4.2±1.0 0.600
Fasting glucose (mg/dL) 81.8±7.6 84.6±5.9 83.2±6.9 0.037
Fasting insulin (uUI/mL) 14.3±8.4 9.9±8.1 12.1±8.5 0.009
HOMA-IR 2.9±2.0 2.0±1.6 2.5±1.9 0.020
Total cholesterol (mg/dL) 162.0±46.0 163.0±34.0 163.0±40.0 0.750 
LDL-cholesterol (mg/dL) 101.0±42.0 101.0±30.0 101.0±36.0 0.638
HDL-cholesterol (mg/dL) 42.0±9.0 42.0±9.0 42.0±9.0 0.795
Triglycerides (mg/dL) 99.0±45.0 102.0±61.0 101.0±54.0 0.875
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subcutaneous fat. By correlating the number of factors for 
MS, only BMI was significant. The lipid profile and the 
glucose levels were not significantly correlated with any of 
the indicators of body composition (Table 3).
Table 4 shows that the distribution of the indicators of 
body composition showed significant differences with the 
progressive increase in insulin resistance. It is noteworthy 
that, for BMI, the differences between the tertiles were even 
more pronounced. 
In the evaluation of cutoffs, the percentage values  of 23.5 
and 36.3 above the reference value of BMI enabled the iden-
tification of insulin resistance and MS, respectively, as they 
reached the largest sum between the values  of sensitivity and 
specificity. The best cutoff point for waist circumference to 
identify insulin resistance was 40% higher than P
75
. 
The sensitivity and specificity obtained for the cutoff 
points of BMI and waist circumference, using as an outcome 
the presence of metabolic syndrome and insulin resistance, 
are shown in Figure 1. 
Discussion
There was a high percentage of MS in the studied popula-
tion (45.5%). Published data reported prevalence rates of MS 
among 28.7 and 44% in obese adolescents(3,16-18). Possibly, 
the high frequency found in this study results from the 
sample coming from a University service that treats the most 
severe cases of obesity. The diversity of prevalence rates can 
be explained by the fact that there is no universal criterion 
available to diagnose metabolic syndrome in children and 
adolescents regarding its components and cutoff points(3,19,20). 
Chen and Berenson(21) highlighted the limited criteria to 
characterize MS in children and adolescents and reinforced 
the importance of a universal definition. However, it remains 
worrisome that almost 50% of patients, still quite young 
*Mann-Whitney’s test for variables related to insulin resistance; **t test for variables related to metabolic syndrome
BMI: body mass index; BF: body fat; SF: subcutaneous fat; TC: total cholesterol; TG: triglycerides; SBP: systolic blood pressure; DBP: diastolic 
blood pressure; WC: waist circumference; HOMA-IR: Homeostasis Model Assessment for Insulin Resistance 
Table 2 - Characteristics of the subjects according to insulin resistance and metabolic syndrome
Insulin resistance
p-value*
Metabolic syndrome
p-value**Absent
(n=56)
Present
(n=23)
Absent
(n=43)
Present
(n=36)
Age (years) 12.81±2.4 12.8±2.1 0.750 12.7±2.4 12.9±2.3 0.644
BMI (kg/m2) 30.6±4.6 35.3±5.3 0.001 30.5±4.4 33.8±5.6 0.006
BF (%) 40.3±5.1 44.7±3.6 0.001 41.3±4.6 41.9±5.8 0.645
SF (cm) 4.0±0.9 4.8±1.1 0.003 4.1±1.1 4.3±1.0 0.338
TC (mg/dL) 165.0±45.0 158.0±25.0 0.456 155.0±36.0 172.0±43.0 0.061
LDL-cholesterol (mg/dL) 102.0±41.0 98.0±20.0 0.706 93.0±31.0 110.0±40.0 0.036
HDL-cholesterol (mg/dL) 44.0±9.0 38.0±8.0 0.006 – – –
TG (mg/dL) 95.0±56.0 114.0±47.0 0.051 – – –
SBP (mmHg) 113.0±16.0 114.0±11.0 0.356 – – –
DBP (mmHg) 73.0±11.0 76.0±9.0 0.182 – – –
WC (cm) 98.7±11.2 109.0±13.1 0.002 – – –
Insulin (uUI/mL) – – – 9.6±6.6 15.1±9.6 0.005
HOMA-IR – – – 1.9±1.3 3.1±2.2 0.004
%BF: percentage of body fat; BMI: body mass index; WC: waist 
circumference; SF: subcutaneous fat; HOMA-IR: Homeostasis Model 
Assessment for Insulin Resistance; MS: metabolic syndrome. *p<0.01
Table 3 - Correlations between anthropometric and body 
composition indicators with components of metabolic syndrome 
and insulin resistance
%BF BMI WC SF
r r r r
Systolic blood 
pressure 0.099 0.501* 0.564* 0.319*
Diastolic blood 
pressure 0.053 0.471* 0.534* 0.329*
Fasting glucose -0.025 0.151 0.125 0.165
HDL-cholesterol 0.025 -0.134 -0.071 -0.028
Triglycerides 0.003 0.003 0.162 -0.069
HOMA-IR 0.347* 0.469* 0.428* 0.388*
Number of factors 
for MS 0.064 0.295* – 0.196
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(mean age 12.8 years), are referred to the Obesity Clinic 
with a number of associated comorbidities. 
Studies sought to determine the features associated with 
MS in different age groups. In the present study, there was 
a higher correlation coefficient between the number of fac-
tors for MS and BMI, when compared to other measures 
of body composition(8). The presence of risk factors for MS 
seems to be more frequent in obese children compared to 
those with normal weight or overweight, demonstrating 
that increased values of BMI increase the occurrence of 
other risk factors for MS(2,8).
Insulin resistance as assessed by HOMA-IR was observed 
in 29.1% of the population studied. Higher prevalences were 
published by other authors(17,22). This variation in the prevalence 
of insulin resistance in the studies can be explained by the lack 
of a reference cutoff point to rate the results of the patients(15,23).
It was observed an association between insulin re-
sistance and decreased HDL-cholesterol in the present 
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p=0.0001 p=0.0001 p=0.007
Cutoff point: 40.0* Cutoff point: 23.5* Cutoff point: 36.3*
Sensitivity: 65.22 Sensitivity: 86.96 Sensitivity: 44.44
Specificity: 83.93 Specificity: 58.93 Specificity: 86.05
*the cutoff corresponds to the percentage above the value considered for the diagnosis 
WC: waist circumference; HOMA-IR: Homeostasis Model Assessment for Insulin Resistance; BMI: body mass index; MS: metabolic syndrome; 
AUC: area under the curve; SE: standard error; 95%CI: 95% confidence interval
Figure 1 - Area under the curve, cutoff, sensitivity and specificity for anthropometric indicators in the identification of insulin 
resistance and metabolic syndrome
*Kruskal-Wallis test: difference between the 1st and the 3rd tertile
Table 4 - Distribution of components of metabolic syndrome and indicators of body composition according to tertiles of insulin 
resistance in subjects evaluated 
Insulin resistance
1st tertile
0.37–1.56
n=27
2nd tertile
1.57–3.05
n=26
3rd tertile
3.06–10.44
n=26
p-value
Waist circumference (cm)* 95.7±10.7 101.9±11.6 107.7±13.0 0.007
Body mass index (kg/m2)* 29.3±3.7 32.1±5.1 34.7±5.5 0.001
Body fat (%)* 39.9±6.0 40.9±4.4 44.0±3.9 0.008
Subcutaneous fat (cm)* 3.8±1.0 4.1±0.9 4.7±1.1 0.012
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study. This relationship was also noted by other authors 
in adolescents(9). This finding agrees with the hypothesis 
that the production of HDL-cholesterol is linked to the 
degradation of LDL-cholesterol particles, which are im-
paired by insulin resistance(24). 
Insulin resistance was significantly correlated with all 
indicators of body composition and is consistent with 
other studies(2,9,10). When adolescences were grouped into 
tertiles, according to the HOMA-IR to check if the indi-
cators of body composition increase according to insulin 
resistance, it was observed that all indicators of body com-
position (BMI, body fat percentage, waist circumference, 
and subcutaneous fat) raised their means as the values  of 
HOMA- IR increased. 
For Sinaiko et al(25), insulin resistance correlates signifi-
cantly with body fat. We found similar data in a study con-
ducted in the United States, in which obese, overweight, and 
normal weight children and adolescents were evaluated, not-
ing that the values  of insulin resistance differed according to 
the degree of obesity, which shows that the interaction of the 
factors obesity duration and amount of body fat can be 
the cause of an increased insulin resistance(2). 
Among girls, the mean percentage of body fat and insu-
lin resistance were significantly higher(7). The difference in 
body fat distribution between the sexes may explain this 
increase in the percentage of body fat in girls, as there is 
a redistribution of fat from the extremities to the trunk. 
This distribution differs between the sexes, because these 
changes are associated with the levels of estrogen and 
testosterone. The increase in the percentage of body fat in 
girls may be associated with the significantly higher means 
of insulin resistance.
Given their peculiarities, prepubertal children have 
been studied separately from those already in puberty, in 
which the effects of hormonal changes are already pres-
ent, possibly contributing to the exacerbation of insulin 
resistance(26). In this regard, it is known that insulin and 
HOMA-IR increase with the progress of puberty. There is 
evidence that insulin resistance varies according to pubertal 
development: it increases significantly between Tanner 
stages 1 and 2, remains stable in stages 2, 3, and 4, and 
drops significantly in stage 5(27). In the present study, there 
were no differences in HOMA- IR regarding age group 
in the groups with and without insulin resistance. This 
resistance, physiologically induced by puberty, should not 
be interpreted as a bias in the estimated frequency of its 
presence. The fact that puberty may have an effect on the 
prevalence of insulin resistance can be viewed as a major 
factor in the development of adiposity and in the metabolic 
complications that can be generated(28).
As for the association of MS with insulin resistance, it 
was observed that in the presence of MS, patients presented 
a 4.1-fold increased chance of developing insulin resistance. 
The mean insulin resistance also differed positively when 
patients with and without MS were compared. Thus, it 
was demonstrated that the prevalence of risk factors for MS 
rises with the increase of insulin resistance. In other studies 
with humans, there was also association between insulin 
resistance and MS(2,22).
When MS components were correlated with indicators of 
body composition, it was found that systolic and diastolic 
blood pressures were positively correlated with BMI(2,9,10), 
waist circumference(9,10), and subcutaneous fat. Casonatto 
et al(29) observed that adolescents from 10 to 13 years with 
high waist circumference had mean values  of blood pressure 
significantly higher than those with normal waist circumfer-
ence, concluding that abdominal obesity is associated with 
increased blood pressure in adolescents. 
In the present study, there was no positive correlation 
between indicators of body composition with HDL-
cholesterol, triglycerides, and fasting glucose. These 
data seem controversial when compared to other studies. 
Similarly, Weiss et al(2) found no correlation between BMI 
and triglycerides, unlike Nasreddine et al(9), who observed 
a positive correlation of BMI and waist circumference 
with HDL-cholesterol and triglycerides, but found no 
correlation between BMI and waist circumference with 
fasting glucose either.
Anthropometric variables, BMI, and waist circumfer-
ence were significant predictors of insulin resistance, 
and BMI presented predictive power for MS. However, 
BMI appears to be more effective in predicting insulin 
resistance when compared to waist circumference. It is 
believed that the use of anthropometric indexes is relevant 
when it has advantages, such as speed of execution and 
no need of additional tests. 
The cutoff points found in the studied group are ap-
plicable only to obese adolescents. Due to the increasing 
prevalence of childhood obesity, which results in increased 
morbidity and mortality from cardiovascular disease in 
adulthood, the establishment of a cutoff point for BMI 
and waist circumference to identify insulin resistance 
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and MS can be useful to identify children at increased 
cardiovascular risk. 
A possible limitation of this study relates to the use 
of the measure of subcutaneous fat, because there are no 
studies in the literature involving obese adolescents and 
comparing insulin resistance and components of MS with 
subcutaneous fat, since the measurement of visceral fat is 
more commonly used due to its higher correlation with 
cardiovascular diseases.
We conclude that the prevalence of metabolic syndrome 
and insulin resistance in obese adolescents is high. Indicators 
of body composition (BMI, body fat percentage, waist cir-
cumference, and subcutaneous fat) were positively correlated 
with insulin resistance, but only BMI was correlated with 
components of MS. Insulin resistance was significantly as-
sociated with HDL-cholesterol and with MS, and the BMI 
was the most effective anthropometric indicator in identify-
ing insulin resistance.
